Usability of an Atrial Fibrillation Anticoagulation Decision-Support Tool

Journal of Primary Care & Community Health

Volumn 2, Issue 2, 2011, Pages 100-106

  Wess, Mark L ^a   Saleem, Jason J ^a,b,c   Tsevat, Joel ^a,d   Luckhaupt, Sara E ^a   Johnston, Joseph A ^e   Kopke, Jonathan E ^f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c REGENSTRIEF INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f Collaborative Information Systems ^*  (United States)

Author keywords

anticoagulation; atrial fibrillation; decision aid; decision support; usability testing

Indexed keywords

EID: 84871641245     PISSN: 21501319     EISSN: 21501327     Source Type: Journal    
DOI: 10.1177/2150131910387608     Document Type: Article

References (35)

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.
2. Ruigomez A Johansson S Wallander MA Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002;55:358-363.
3. Wolf PA Abbott RD Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983-988.
4. Singer DE. Overview of the randomized trials to prevent stroke in atrial fibrillation. Ann Epidemiol. 1993;3:563-567.
5. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med. 1990;323:1505-1511.
6. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993;342:1255-1262.
7. Petersen P Boysen G Godtfredsen J Andersen ED Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989;1:175-179.
8. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991;84:527-539.
9. Fang MC Stafford RS Ruskin JN Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004;164:55-60.
10. Johnston JA Cluxton RJ Jr. Heaton PC Guo JJ Moomaw CJ Eckman MH. Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med. 2003;163:1705-1710.
11. Reynolds MR Shah J Essebag V. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006;97:538-543.
12. Ogilvie IM Newton N Welner SA Cowell W Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123:638-645,e634.
13. Zimetbaum PJ Thosani A Yu HT. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med. 2010;123:446-453.
14. Hylek EM Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
15. Fang MC Chang Y Hylek EM. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004;141:745-752.
16. Levine MN Raskob G Beyth RJ Kearon C Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:287S-310S.
17. Singer DE Albers GW Dalen JE Go AS Halperin JL Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:429S-456S.
18. Landefeld CS Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144-152.
19. Eckman MH Pauker SG, eds. decision analytical issues in the management of atrial fibrillation. In: Falk RH Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. Philadelphia, PA: Lippincott-Raven Publishers; 1997.
20. Eckman MH Levine HJ Salem DN Pauker SG. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1998;114:699S-714S.
21. Eckman MH Falk RH Pauker SG. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 1998;158:1669-1677.
22. Johnston JA Eckman MH. Use of regression modeling to simulate patient-specific decision analysis for patients with nonvalvular atrial fibrillation. Med Decis Making. 2003;23:361-368.
23. Wess ML Schauer DP Johnston JA. Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med. 2008;23:411-417.
24. Man-Son-Hing M Laupacis A O’Connor AM. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA. 1999;282:737-743.
25. Thomson R Robinson A Greenaway J Lowe P. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Saf Health Care. 2002;11:25-31.
26. Holbrook A Labiris R Goldsmith CH Ota K Harb S Sebaldt RJ. Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CMAJ. 2007;176:1583-1587.
27. University of Cincinatti Center for Clinical Effectiveness. http://www.healthinstitute.uc.edu/reap/NewCase.cfm. Accessed June 30, 2010.
28. Hix D Hartson HR. Developing User Interfaces: Ensuring Usability Throughout Product and Process. New York: John Wiley & Sons, Inc; 1993.
29. Lewis JR. IBM Computer Usability Satisfaction Questionnaires: psychometric evaluation and instructions for use. Int J Hum Comput Interact. 1995;7:57-78.
30. Nielsen J. Estimating the number of subjects needed for a thinking aloud test. Int J Hum Comput Interact. 1994;41:385-397.
31. Lewis JR. Sample sizes for usability studies: additional considerations. Hum Factors. 1994;36:368-378.
32. Linder JA Rose AF Palchuk MB. Decision support for acute problems: the role of the standardized patient in usability testing. J Biomed Inform. 2006;39:648-655.
33. Carroll C Marsden P Soden P Naylor E New J Dornan T. Involving users in the design and usability evaluation of a clinical decision support system. Comput Methods Programs Biomed. 2002;69:123-135.
34. Chang YJ Tsai CY Yeh ML Li YC. Assessing the impact of user interface to the usability of a clinical decision support system. AMIA Annu Symp Proc. 2003:808.
35. Ericsson K Simon H. Verbal Reports as Data. Cambridge, MA: MIT Press; 1993.